6/10
05:19 am
krys
Krystal Biotech, Virtu, StepStone, Cactus, Tidewater to join S&P 600 [Seeking Alpha]
Low
Report
Krystal Biotech, Virtu, StepStone, Cactus, Tidewater to join S&P 600 [Seeking Alpha]
6/7
06:09 pm
krys
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
Low
Report
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
6/5
07:00 am
krys
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Medium
Report
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
6/3
04:44 pm
krys
Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio? [Yahoo! Finance]
Low
Report
Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio? [Yahoo! Finance]
5/23
01:04 pm
krys
Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why [Yahoo! Finance]
Low
Report
Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why [Yahoo! Finance]
5/15
07:12 am
krys
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference [Yahoo! Finance]
Low
Report
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference [Yahoo! Finance]
5/15
07:00 am
krys
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
Low
Report
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
5/8
07:00 am
krys
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
Low
Report
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
5/7
11:21 am
krys
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/7
11:13 am
krys
Company News for May 7, 2024 [Yahoo! Finance]
Low
Report
Company News for May 7, 2024 [Yahoo! Finance]
5/6
02:22 pm
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
5/6
08:13 am
krys
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
High
Report
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
5/6
08:00 am
krys
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
Medium
Report
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
5/3
09:56 am
krys
Why Krystal Biotech (KRYS) Might Surprise This Earnings Season [Yahoo! Finance]
Low
Report
Why Krystal Biotech (KRYS) Might Surprise This Earnings Season [Yahoo! Finance]
5/2
07:13 am
krys
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting [Yahoo! Finance]
Low
Report
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting [Yahoo! Finance]
5/2
07:00 am
krys
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
Low
Report
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
4/26
07:00 am
krys
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
Medium
Report
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
4/23
11:08 am
krys
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround [Yahoo! Finance]
Low
Report
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround [Yahoo! Finance]
4/22
02:11 pm
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
4/22
07:15 am
krys
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung [Yahoo! Finance]
Low
Report
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung [Yahoo! Finance]
4/22
07:00 am
krys
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
Low
Report
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
4/16
08:40 am
krys
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
Low
Report
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
4/15
10:27 am
krys
Recent 3.8% pullback isn't enough to hurt long-term Krystal Biotech (NASDAQ:KRYS) shareholders, they're still up 437% over 5 years [Yahoo! Finance]
Low
Report
Recent 3.8% pullback isn't enough to hurt long-term Krystal Biotech (NASDAQ:KRYS) shareholders, they're still up 437% over 5 years [Yahoo! Finance]
4/4
07:19 am
krys
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting [Yahoo! Finance]
Low
Report
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting [Yahoo! Finance]
4/4
07:00 am
krys
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
Low
Report
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting